Virtus LifeSci Biotech Clinical Trials ETF (BBC) Holdings
BBC holdings summary
as of Oct 25, 2026- Holdings
- 129 positions listed
- Top 10 weight
- 15.2% of net assets
- Effective holdings
- 110 equal-weight equivalent
- Largest holding
- KOD 2.08% Kodiak Sciences Inc.
- Annual turnover
- 65.1% of the portfolio traded
Top 1015.2%
Top 2530.9%
Top 5052.9%
Top 10087.9%
All BBC holdings
129 holdings
| # | Name | ||||||
|---|---|---|---|---|---|---|---|
| 1 | KOD | Kodiak Sciences Inc. | Healthcare | 2.08% | $832,558.93 | $5.39B | — |
| 2 | TRAX | First Tracks Biotherapeutics | Healthcare | 2.07% | $829,279.41 | $1.23B | — |
| 3 | ABCL | AbCellera Biologics Inc. | Healthcare | 1.84% | $734,373.21 | $3.82B | — |
| 4 | XNCR | Xencor, Inc. | Healthcare | 1.72% | $688,459.88 | $1.70B | — |
| 5 | AMLX | Amylyx Pharmaceuticals, Inc. | Healthcare | 1.57% | $629,628.44 | $3.31B | — |
| 6 | ORIC | ORIC Pharmaceuticals, Inc. | Healthcare | 1.24% | $497,687.63 | $1.28B | — |
| 7 | SGP | SpyGlass Pharma, Inc. | Healthcare | 1.20% | $480,610.11 | $802.8M | — |
| 8 | MANE | Veradermics, Incorporated | Healthcare | 1.18% | $472,051.35 | $4.55B | — |
| 9 | NRIX | Nurix Therapeutics, Inc. | Healthcare | 1.15% | $460,413.05 | $2.67B | 10.0 |
| 10 | SLS | SELLAS Life Sciences Group, Inc. | Healthcare | 1.14% | $454,533.90 | $2.02B | — |
| 11 | DFTX | Definium Therapeutics, Inc. | Healthcare | 1.13% | $450,134.54 | $4.31B | — |
| 12 | LBRX | LB Pharmaceuticals Inc | Healthcare | 1.10% | $441,535.79 | $1.19B | 367.4 |
| 13 | MBX | MBX Biosciences, Inc. | Healthcare | 1.08% | $432,497.11 | $2.39B | — |
| 14 | PRME | Prime Medicine, Inc. | Healthcare | 1.08% | $430,377.41 | $629.4M | — |
| 15 | REPL | Replimune Group, Inc. | Healthcare | 1.07% | $428,057.75 | $1.02B | — |
| 16 | ZBIO | Zenas BioPharma, Inc. | Healthcare | 1.06% | $423,578.40 | $1.62B | — |
| 17 | VOR | Vor Biopharma Inc. | Healthcare | 1.06% | $423,498.41 | $977.0M | 0.1 |
| 18 | VRDN | Viridian Therapeutics, Inc. | Healthcare | 1.06% | $422,738.52 | $2.16B | — |
| 19 | KYMR | Kymera Therapeutics, Inc. | Healthcare | 1.05% | $418,899.08 | $8.62B | — |
| 20 | FDMT | 4D Molecular Therapeutics, Inc. | Healthcare | 1.02% | $407,460.75 | $670.7M | — |
| 21 | MAZE | Maze Therapeutics, Inc. | Healthcare | 1.02% | $406,580.87 | $1.53B | — |
| 22 | PCVX | Vaxcyte, Inc. | Healthcare | 1.00% | $399,181.95 | $10.01B | — |
| 23 | RVMD | Revolution Medicines, Inc. | Healthcare | 0.99% | $396,062.40 | $38.14B | — |
| 24 | MNPR | Monopar Therapeutics Inc. | Healthcare | 0.99% | $394,982.56 | $465.0M | — |
| 25 | BHVN | Biohaven Ltd. | Healthcare | 0.97% | $386,103.85 | $1.63B | — |
| 26 | IDYA | IDEAYA Biosciences, Inc. | Healthcare | 0.96% | $385,503.94 | $3.17B | — |
| 27 | RLAY | Relay Therapeutics, Inc. | Healthcare | 0.95% | $380,744.63 | $3.57B | — |
| 28 | EWTX | Edgewise Therapeutics, Inc. | Healthcare | 0.95% | $379,704.78 | $4.04B | — |
| 29 | JANX | Janux Therapeutics, Inc. | Healthcare | 0.95% | $378,904.90 | $1.01B | — |
| 30 | VIR | Vir Biotechnology, Inc. | Healthcare | 0.95% | $378,584.95 | $1.69B | — |
| 31 | SEPN | Septerna, Inc. | Healthcare | 0.94% | $376,945.18 | $1.70B | — |
| 32 | SYRE | Spyre Therapeutics, Inc. | Healthcare | 0.93% | $371,545.97 | $7.47B | — |
| 33 | ACHV | Achieve Life Sciences, Inc. | Healthcare | 0.92% | $366,746.67 | $657.8M | — |
| 34 | RXRX | Recursion Pharmaceuticals, Inc. | Healthcare | 0.92% | $366,386.72 | $1.86B | — |
| 35 | ORKA | Oruka Therapeutics, Inc. | Healthcare | 0.91% | $364,227.03 | $4.76B | — |
| 36 | PVLA | Palvella Therapeutics, Inc | Healthcare | 0.90% | $360,187.62 | $1.73B | — |
| 37 | CGEM | Cullinan Oncology, Inc. | Healthcare | 0.89% | $355,988.23 | $794.7M | — |
| 38 | BLTE | Belite Bio, Inc. | Healthcare | 0.89% | $354,348.47 | $5.75B | — |
| 39 | CGON | CG Oncology, Inc. | Healthcare | 0.87% | $347,029.53 | $5.31B | — |
| 40 | IRON | Disc Medicine, Inc. | Healthcare | 0.86% | $344,669.88 | $2.18B | — |
| 41 | ANRO | Alto Neuroscience, Inc. | Healthcare | 0.86% | $342,270.23 | $861.0M | — |
| 42 | SMMT | Summit Therapeutics Inc. | Healthcare | 0.85% | $341,190.38 | $11.67B | — |
| 43 | DMRA | Damora Therapeutics, Inc. | Healthcare | 0.83% | $333,431.51 | $1.14B | — |
| 44 | ANL | Adlai Nortye Ltd. ADR | Healthcare | 0.83% | $332,431.66 | $710.3M | — |
| 45 | AURA | Aura Biosciences, Inc. | Healthcare | 0.83% | $330,072.00 | $632.6M | — |
| 46 | INBX | Inhibrx, Inc. | Healthcare | 0.82% | $327,872.32 | $1.32B | — |
| 47 | TKM | Arbutus Biopharma Corp | Other | 0.82% | $326,752.48 | — | — |
| 48 | PHVS | Pharvaris N.V. | Healthcare | 0.82% | $326,512.52 | $1.95B | — |
| 49 | RZLT | Rezolute, Inc. | Healthcare | 0.81% | $324,832.76 | $346.3M | — |
| 50 | ARVN | Arvinas, Inc. | Healthcare | 0.81% | $324,632.79 | $449.7M | 26.8 |
| 51 | RGNX | REGENXBIO Inc. | Healthcare | 0.81% | $322,433.11 | $457.1M | — |
| 52 | ERAS | Erasca, Inc. | Healthcare | 0.81% | $322,353.12 | $4.68B | — |
| 53 | GENB | Generate Biomedicines, Inc. | Healthcare | 0.81% | $322,233.14 | $1.55B | — |
| 54 | PRTA | Prothena Corporation plc | Healthcare | 0.80% | $319,713.51 | $428.7M | — |
| 55 | MGTX | MeiraGTx Holdings plc | Healthcare | 0.79% | $315,954.05 | $891.3M | 10.7 |
| 56 | IMMX | Immix Biopharma, Inc. | Healthcare | 0.79% | $315,474.12 | $661.6M | — |
| 57 | NTLA | Intellia Therapeutics, Inc. | Healthcare | 0.78% | $313,514.41 | $1.60B | — |
| 58 | CMPS | COMPASS Pathways plc | Healthcare | 0.78% | $313,434.42 | $1.49B | — |
| 59 | JBIO | Jade Biosciences, Inc. | Healthcare | 0.77% | $308,635.12 | $856.7M | — |
| 60 | IMNM | Immunome, Inc. | Healthcare | 0.77% | $308,235.18 | $1.94B | — |
| 61 | SRRK | Scholar Rock Holding Corporation | Healthcare | 0.77% | $306,595.41 | $4.86B | — |
| 62 | DSGN | Design Therapeutics, Inc. | Healthcare | 0.77% | $306,595.41 | $645.2M | — |
| 63 | PRAX | Praxis Precision Medicines, Inc. | Healthcare | 0.77% | $306,075.49 | $6.75B | — |
| 64 | CADL | Candel Therapeutics, Inc. | Healthcare | 0.75% | $299,516.44 | $626.7M | — |
| 65 | ELVN | Enliven Therapeutics, Inc. | Healthcare | 0.73% | $293,157.37 | $2.73B | — |
| 66 | COGT | Cogent Biosciences, Inc. | Healthcare | 0.73% | $291,917.55 | $5.12B | — |
| 67 | GHRS | GH Research PLC | Healthcare | 0.73% | $290,397.77 | $1.25B | — |
| 68 | ELYM | Eliem Therapeutics Inc | Healthcare | 0.72% | $289,957.83 | — | — |
| 69 | BCYC | Bicycle Therapeutics plc | Healthcare | 0.72% | $288,438.06 | $241.5M | — |
| 70 | ASMB | Assembly Biosciences, Inc. | Healthcare | 0.72% | $288,118.10 | $409.0M | 19.3 |
| 71 | DNTH | Dianthus Therapeutics, Inc. | Healthcare | 0.72% | $287,998.12 | $4.03B | — |
| 72 | CLDX | Celldex Therapeutics, Inc. | Healthcare | 0.72% | $287,918.13 | $2.16B | — |
| 73 | CRVS | Corvus Pharmaceuticals, Inc. | Healthcare | 0.72% | $287,318.22 | $800.8M | — |
| 74 | IMVT | Immunovant, Inc. | Healthcare | 0.69% | $276,999.72 | $5.52B | — |
| 75 | MLYS | Mineralys Therapeutics, Inc. | Healthcare | 0.69% | $274,920.02 | $1.79B | — |
| 76 | SANA | Sana Biotechnology, Inc. | Healthcare | 0.69% | $274,720.05 | $679.5M | — |
| 77 | ANAB | AnaptysBio, Inc. | Healthcare | 0.69% | $274,640.06 | $1.39B | — |
| 78 | VERA | Vera Therapeutics, Inc. | Healthcare | 0.68% | $273,600.21 | $2.01B | — |
| 79 | PROK | ProKidney Corp. | Healthcare | 0.68% | $273,040.29 | $530.9M | — |
| 80 | VKTX | Viking Therapeutics, Inc. | Healthcare | 0.68% | $272,400.39 | $3.20B | — |
| 81 | ALT | Altimmune, Inc. | Healthcare | 0.68% | $271,560.51 | $427.9M | — |
| 82 | RCKT | Rocket Pharmaceuticals, Inc. | Healthcare | 0.68% | $270,640.64 | $239.3M | — |
| 83 | QURE | uniQure N.V. | Healthcare | 0.67% | $268,920.89 | $1.51B | — |
| 84 | STOK | Stoke Therapeutics, Inc. | Healthcare | 0.67% | $267,281.13 | $1.56B | — |
| 85 | DYN | Dyne Therapeutics, Inc. | Healthcare | 0.66% | $265,561.38 | $2.66B | — |
| 86 | NGNE | Neurogene Inc. | Healthcare | 0.66% | $265,201.43 | $465.3M | — |
| 87 | SLDB | Solid Biosciences Inc. | Healthcare | 0.66% | $262,681.80 | $593.0M | — |
| 88 | BEAM | Beam Therapeutics Inc. | Healthcare | 0.66% | $262,441.84 | $2.42B | — |
| 89 | BCAX | Bicara Therapeutics Inc. | Healthcare | 0.65% | $259,042.33 | $1.11B | — |
| 90 | SVRA | Savara Inc. | Healthcare | 0.65% | $258,242.45 | $914.3M | — |
| 91 | ADGI | Adagio Therapeutics Inc | Healthcare | 0.64% | $256,442.71 | — | — |
| 92 | ANNX | Annexon, Inc. | Healthcare | 0.64% | $256,282.73 | $646.5M | — |
| 93 | LXRX | Lexicon Pharmaceuticals, Inc. | Healthcare | 0.63% | $250,963.50 | $676.3M | — |
| 94 | CELC | Celcuity Inc. | Healthcare | 0.62% | $248,923.80 | $2.77B | — |
| 95 | IMTX | Immatics N.V. | Healthcare | 0.61% | $242,724.70 | $1.02B | — |
| 96 | RCUS | Arcus Biosciences, Inc. | Healthcare | 0.61% | $242,604.72 | $2.82B | — |
| 97 | CTMX | CytomX Therapeutics, Inc. | Healthcare | 0.60% | $241,564.87 | $496.8M | — |
| 98 | OCS | Oculis Holding AG | Healthcare | 0.60% | $240,005.10 | $449.0M | — |
| 99 | TYRA_old | TYRA | Healthcare | 0.59% | $235,525.75 | — | — |
| 100 | BCTG | BCTG Acquisition Corp | Financial Services | 0.58% | $233,885.99 | — | — |
| 101 | AKTS | Akoustis Technologies, Inc. | Healthcare | 0.58% | $231,366.35 | $837.6M | — |
| 102 | CBIO | Crescent Biopharma, Inc. | Healthcare | 0.58% | $230,726.45 | $439.8M | — |
| 103 | TSHA | Taysha Gene Therapies, Inc. | Healthcare | 0.56% | $225,567.20 | $1.18B | — |
| 104 | ALLO | Allogene Therapeutics, Inc. | Healthcare | 0.56% | $222,207.69 | $452.6M | — |
| 105 | XENE | Xenon Pharmaceuticals Inc. | Healthcare | 0.54% | $216,968.45 | $3.24B | — |
| 106 | AVBP | ArriVent BioPharma, Inc. | Healthcare | 0.54% | $215,528.66 | $821.5M | — |
| 107 | LXEO | Lexeo Therapeutics, Inc. | Healthcare | 0.54% | $214,128.86 | $216.7M | — |
| 108 | RAPP | Rapport Therapeutics, Inc. | Healthcare | 0.53% | $211,649.22 | $1.32B | — |
| 109 | MLTX_old | Multex Com Inc | Other | 0.53% | $211,049.31 | — | — |
| 110 | TECX | Tectonic Therapeutic Inc. | Healthcare | 0.52% | $209,249.57 | $403.7M | — |
| 111 | NKTR | Nektar Therapeutics | Healthcare | 0.51% | $205,770.08 | $1.22B | — |
| 112 | OLMA | Olema Pharmaceuticals, Inc. | Healthcare | 0.51% | $205,010.19 | $575.7M | — |
| 113 | KH6_old | KINGHERO | Other | 0.51% | $204,890.20 | — | — |
| 114 | GLUE | Monte Rosa Therapeutics, Inc. | Healthcare | 0.50% | $200,370.86 | $831.0M | — |
| 115 | WVE | Wave Life Sciences Ltd. | Healthcare | 0.42% | $167,655.62 | $616.8M | — |
| 116 | CABA | Cabaletta Bio, Inc. | Healthcare | 0.41% | $163,576.21 | $239.1M | — |
| 117 | RLMD | Relmada Therapeutics, Inc. | Healthcare | 0.40% | $158,656.93 | $330.7M | — |
| 118 | GPCR | Structure Therapeutics Inc. | Healthcare | 0.39% | $154,937.47 | $1.50B | — |
| 119 | AVTX | Avalo Therapeutics, Inc. | Healthcare | 0.37% | $146,858.64 | $604.4M | — |
| 120 | UPB | Upstream Bio, Inc. | Healthcare | 0.35% | $139,779.67 | $151.2M | — |
| 121 | CMPX | Compass Therapeutics, Inc. | Healthcare | 0.31% | $123,302.07 | $154.9M | — |
| 122 | BBOT | BridgeBio Oncology Therapeutics, Inc. | Healthcare | 0.27% | $109,544.07 | $226.1M | — |
| 123 | MPLT | MapLight Therapeutics, Inc. | Healthcare | 0.24% | $94,786.22 | $427.9M | — |
| 124 | BIOA | BioAge Labs, Inc | Healthcare | 0.23% | $90,746.80 | $222.1M | — |
| 125 | ALMS | Alumis Inc. | Healthcare | 0.23% | $90,066.90 | $792.1M | — |
| 126 | EVMN | Evommune, Inc. | Healthcare | 0.20% | $80,548.29 | $187.6M | — |
| 127 | CAPR | Capricor Therapeutics, Inc. | Healthcare | 0.19% | $75,189.07 | $390.1M | — |
| 128 | SION | Sionna Therapeutics, Inc. | Healthcare | 0.08% | $31,555.41 | $175.6M | — |
| 129 | EYPT | EyePoint Pharmaceuticals, Inc. | Healthcare | 0.02% | $9,838.57 | $250.7M | — |
Weights as a percentage of net assets. Value held = weight × net assets ($40.0M). Market cap and P/E from each company's latest fundamentals (U.S.-listed stocks).
BBC sector breakdown
| Sector | Weight | Holdings | Largest |
|---|---|---|---|
| Healthcare | 97.1% | 125 | KOD, TRAX, ABCL |
| Other | 1.9% | 3 | TKM, MLTX_old, KH6_old |
| Financial Services | 0.6% | 1 | BCTG |
Sum of the weights of the holdings in each sector.
BBC top industries
Biotechnology
94.2%
Drug Manufacturers - Specialty & Generic
1.8%
Medical Care Facilities
0.8%
Shell Companies
0.6%
BBC overlap with other ETFs
| ETF | Fund | Overlap | Shared holdings | Expense ratio |
|---|---|---|---|---|
| IWM | iShares Russell 2000 ETF | 5.4% | 107 of 1,962 | 0.19% |
| VTI | Vanguard Total Stock Market ETF | 0.3% | 107 of 2,941 | 0.03% |
| VXUS | Vanguard Total International Stock ETF | 0.0% | 2 of 8,035 | 0.05% |
| SPY | SPDR S&P 500 ETF | 0.0% | 0 of 502 | 0.09% |
| QQQ | Invesco QQQ ETF | 0.0% | 0 of 101 | 0.17% |
| DIA | SPDR Dow Jones Industrial Average ETF | 0.0% | 0 of 30 | 0.16% |
Overlap = sum over shared holdings of the smaller of the two weights. 100% means identical portfolios.
About the BBC portfolio
Virtus LifeSci Biotech Clinical Trials ETF holds 129 positions. The ten largest make up 15.2% of the fund and the top 50 52.9%, so it behaves like a portfolio of about 110 equally weighted stocks. The biggest positions are Kodiak Sciences Inc. (2.08%), First Tracks Biotherapeutics (2.07%), AbCellera Biologics Inc. (1.84%), Xencor, Inc. (1.72%), Amylyx Pharmaceuticals, Inc. (1.57%).
By sector, Healthcare is 97.1%, Other is 1.9%, Financial Services is 0.6%. Holdings data is from the fund's latest portfolio as reported by EODHD on October 25, 2026; positions change as the fund rebalances.
Related: BBC chart, BBC performance, BBC dividends, BBC overview.
BBC holdings FAQ
How many holdings does BBC have?
BBC holds 129 positions as of October 25, 2026.
What are the top 10 holdings of BBC?
The ten largest holdings are Kodiak Sciences Inc. (2.08%), First Tracks Biotherapeutics (2.07%), AbCellera Biologics Inc. (1.84%), Xencor, Inc. (1.72%), Amylyx Pharmaceuticals, Inc. (1.57%), ORIC Pharmaceuticals, Inc. (1.24%), SpyGlass Pharma, Inc. (1.20%), Veradermics, Incorporated (1.18%), Nurix Therapeutics, Inc. (1.15%), SELLAS Life Sciences Group, Inc. (1.14%). Together they are 15.2% of the fund.
What percentage of BBC is Kodiak Sciences Inc.?
Kodiak Sciences Inc. is the largest holding at 2.08% of net assets, about $832,558.93 of the fund's $40.0M.
Which sector is the largest in BBC?
Healthcare is the largest sector at 97.1%, followed by Other (1.9%) and Financial Services (0.6%), based on the sectors of the individual holdings.
How concentrated is BBC?
The top 10 holdings are 15.2% of the fund. By the effective number of holdings (1 divided by the sum of squared weights) BBC behaves like a portfolio of about 110 equally weighted stocks.